Literature DB >> 15999293

Lumbar bone mineral density in very long-term renal transplant recipients: impact of circulating sex hormones.

Vincent M Brandenburg1, Markus Ketteler, Nicole Heussen, Dirk Politt, Rolf D Frank, Ralf Westenfeld, Thomas H Ittel, Jürgen Floege.   

Abstract

The influence of circulating sex hormones and gender on the bone mineral density (BMD) in long-term renal transplant recipients needs further investigation. We performed a retrospective analysis of lumbar BMD between 6 years and 20 years after renal transplantation. In 67 patients (47+/-12 years, 38 male) with a minimum interval of 72 months after transplantation, lumbar BMD measurements (dual energy X-ray absorptiometry) were performed (=complete cohort). Thirty-one patients (=longitudinal cohort) underwent at least three serial BMD measurements (mean follow-up 39+/-18 months, start at 86+/-22 months). All patients received prednisolone. In the complete cohort, BMD was significantly reduced in comparison to young healthy (mean T-score -1.33+/-1.40) and age-matched controls (mean Z-score -0.91+/-1.45) at 88+/-31 months (p<0.05). Osteopenia or osteoporosis were present in two-thirds of patients. In the longitudinal cohort, a mean annual lumbar BMD loss of -0.6+/-1.9% was detectable equivalent to a -0.03+/-0.15 reduction of Z-scores per year (regression analysis). Impact of hormonal status: In the complete cohort, postmenopausal status was associated with significantly lower BMD levels compared to men (p=0.0441). Women and men within the lowest tertile of sex hormone levels (LH, FSH, DHEAS, testosterone, progesterone, estradiol) did not exhibit significant differences in terms of lumbar BMD compared to those in the highest tertile. The mean annual bone loss was statistically indistinguishable between men and women. There was no significant correlation of sex hormone levels and BMD in men and premenopausal women. In postmenopausal women, however, low estradiol and high LH levels correlated with the extent of annual BMD loss (p<0.05). Our data confirm significantly reduced lumbar T-scores in the very late period after renal transplantation. The lumbar BMD decreased by -0.6+/-1.9% per year. In postmenopausal long-term renal transplant recipients, low estradiol levels were associated with accelerated bone loss.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15999293     DOI: 10.1007/s00198-005-1884-6

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  35 in total

1.  Pamidronate and calcitriol trial for the prevention of early bone loss after renal transplantation.

Authors:  J H Nam; J I Moon; S S Chung; S I Kim; K I Park; Y D Song; K R Kim; H C Lee; K Huh; S K Lim
Journal:  Transplant Proc       Date:  2000-11       Impact factor: 1.066

2.  Missing impact of cyclosporine on osteoporosis in renal transplant recipients.

Authors:  W Grotz; A Mundinger; B Gugel; V Exner; A Reichelt; P Schollmeyer
Journal:  Transplant Proc       Date:  1994-10       Impact factor: 1.066

3.  Association of sex hormone status with the bone loss of renal transplant patients.

Authors:  A M Cueto-Manzano; A J Freemont; J E Adams; B Mawer; R Gokal; A J Hutchison
Journal:  Nephrol Dial Transplant       Date:  2001-06       Impact factor: 5.992

4.  Bone loss in long-term renal transplantation: histopathology and densitometry analysis.

Authors:  A M Cueto-Manzano; S Konel; A J Hutchison; V Crowley; M W France; A J Freemont; J E Adams; B Mawer; R Gokal
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

5.  Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients.

Authors:  W H Grotz; F A Mundinger; J Rasenack; L Speidel; M Olschewski; V M Exner; P J Schollmeyer
Journal:  Nephrol Dial Transplant       Date:  1995-11       Impact factor: 5.992

6.  Bone mineral density after renal transplantation in children.

Authors:  J Feber; P Cochat; P Braillon; F Castelo; X Martin; C Glastre; F Chapuis; L David; P J Meunier
Journal:  J Pediatr       Date:  1994-12       Impact factor: 4.406

7.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Authors:  K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

8.  Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis.

Authors:  J P Devogelaer; H Broll; R Correa-Rotter; D C Cumming; C N De Deuxchaisnes; P Geusens; D Hosking; P Jaeger; J M Kaufman; M Leite; J Leon; U Liberman; C J Menkes; P J Meunier; I Reid; J Rodriguez; A Romanowicz; E Seeman; A Vermeulen; L J Hirsch; A Lombardi; K Plezia; A C Santora; A J Yates; W Yuan
Journal:  Bone       Date:  1996-02       Impact factor: 4.398

9.  Bone mineral density changes within six months of renal transplantation.

Authors:  Ted R Mikuls; Bruce A Julian; Al Bartolucci; Kenneth G Saag
Journal:  Transplantation       Date:  2003-01-15       Impact factor: 4.939

10.  Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women.

Authors:  Libuse Tauchmanovà; Rosa Carrano; Massimo Sabbatini; Michele De Rosa; Francesco Orio; Stefano Palomba; Teresa Cascella; Gaetano Lombardi; Stefano Federico; Annamaria Colao
Journal:  Hum Reprod       Date:  2004-03-11       Impact factor: 6.918

View more
  8 in total

Review 1.  Osteoporosis after renal transplantation.

Authors:  Evangelia Dounousi; Konstantinos Leivaditis; Theodoros Eleftheriadis; Vassilios Liakopoulos
Journal:  Int Urol Nephrol       Date:  2014-11-11       Impact factor: 2.370

2.  Protective effect of female gender against bone loss in the forearm following clean-cut tendon injuries, repair, and passive mobilization.

Authors:  Kadir Ertem; Ersoy Kekilli; Yunus Karakoc; Saim Yologlu; Fethi Ceylan
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 3.  Bone disease after renal transplantation.

Authors:  Hartmut H Malluche; Marie-Claude Monier-Faugere; Johann Herberth
Journal:  Nat Rev Nephrol       Date:  2009-11-17       Impact factor: 28.314

4.  Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up.

Authors:  F P Tillmann; M Schmitz; M Jäger; R Krauspe; L C Rump
Journal:  Int Urol Nephrol       Date:  2015-10-26       Impact factor: 2.370

5.  CKD-MBD post kidney transplantation.

Authors:  Dieter Haffner; Maren Leifheit-Nestler
Journal:  Pediatr Nephrol       Date:  2019-12-19       Impact factor: 3.714

Review 6.  Mechanism and Treatment Strategy of Osteoporosis after Transplantation.

Authors:  Lei Song; Xu-Biao Xie; Long-Kai Peng; Shao-Jie Yu; Ya-Ting Peng
Journal:  Int J Endocrinol       Date:  2015-07-27       Impact factor: 3.257

Review 7.  Risk Factors and Management of Osteoporosis Post-Transplant.

Authors:  Karthik Kovvuru; Swetha Rani Kanduri; Pradeep Vaitla; Rachana Marathi; Shiva Gosi; Desiree F Garcia Anton; Franco H Cabeza Rivera; Vishnu Garla
Journal:  Medicina (Kaunas)       Date:  2020-06-19       Impact factor: 2.430

8.  Pancreas-kidney transplantation is associated with reduced fracture risk compared with kidney-alone transplantation in men with type 1 diabetes.

Authors:  Lucas E Nikkel; Sapna P Iyer; Sumit Mohan; Amy Zhang; Donald J McMahon; Bekir Tanriover; David J Cohen; Lloyd Ratner; Christopher S Hollenbeak; Mishaela R Rubin; Elizabeth Shane; Thomas L Nickolas
Journal:  Kidney Int       Date:  2013-01-02       Impact factor: 10.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.